rxstat › Shortages › Tofacitinib

Tofacitinib shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Tofacitinib has no current shortage reported in Canada. It has been in shortage before; the history is below.

A JAK inhibitor used to treat rheumatoid arthritis and other inflammatory conditions.

Products affected
0 / 3
Reports on file
4

Shortage history

2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
AURO-TOFACITINIB
10MG · TABLET · AURO PHARMA INC
DIN 02530015 · ended Jul 24, 2025 · Demand increase for the drug.
Resolved
TARO-TOFACITINIB
5MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02511304 · ended May 8, 2025 · Disruption of the manufacture of the drug.
Resolved
AURO-TOFACITINIB
10MG · TABLET · AURO PHARMA INC
DIN 02530015 · ended Aug 28, 2024 · Demand increase for the drug.
Resolved
AURO-TOFACITINIB
5MG · TABLET · AURO PHARMA INC
DIN 02530007 · ended Aug 28, 2024 · Demand increase for the drug.

What's happening

There are no active shortage reports for Tofacitinib. Health Canada has 4 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Recent changes

Common questions

What is Tofacitinib used for?

A JAK inhibitor used to treat rheumatoid arthritis and other inflammatory conditions.

When will Tofacitinib be back in stock in Canada?

Tofacitinib has no active shortage; supply is normal per Health Canada reports.

Why is Tofacitinib in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Apremilast Widespread shortage 2 of 3 reported products affected Adalimumab (Hulio) Partial shortage 1 of 7 reported products affected Apremilast Partial shortage 1 of 1 reported products affected · est. return Sep 25, 2026 Basiliximab (Simulect) Partial shortage 1 of 1 reported products affected Cyclosporine (Restasis Multidose) Partial shortage 1 of 9 reported products affected · est. return Jul 30, 2027 Fingolimod (Gilenya) Partial shortage 3 of 8 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.